Literature DB >> 16201279

Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma.

Yueqing Guo1, Xu Zhou, Enyu Liu, Xingrui Li, Jinwen Liu, Zhifang Yang, Jilin Yi.   

Abstract

To investigate the difference in expression of hTERT gene between HbsAg-positive human hepatocellular carcinoma (HCC) and HbsAg-negative HCC and to explore the relationship between HBV infection and hTERT gene expression in HCC. The expression of hTERT protein in 30 cases of HbsAg positive HCC and 17 cases of HbsAg negative HCC was detected by immunohistochemistry (SP method), and the expression of hTERT mRNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR). t-test, Chi-squared test and cochran- armitage trend test were used to see whether there was an interrelation between HBsAg and hTERT gene in HCC. The expression of hTERT protein was mostly located in plasm and occasionally in the nucleus of liver cancer cells. The positive rate of hTERT protein and hTERT mRNA in HbsAg positive HCC- 93.33% (28/30) and 83.33% (25/30) respectively which were much higher than those in HbsAg negative HCC- 52.94% (9/17), 47.06% (8/17) (P<0.01) respectively. HbsAg is related to hTERT gene expression in human hepatocellular carcinoma. The hTERT gene activated by the efficacious ingredient of HBV may play an important role in hepatocellular transformation and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201279     DOI: 10.1007/bf02828150

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.

Authors:  H F Hsieh; H J Harn; S C Chiu; Y C Liu; W Y Lui; L I Ho
Journal:  Liver       Date:  2000-04

2.  The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions.

Authors:  Sun-Hee Leem; J Arturo Londoño-Vallejo; Jung-Hyun Kim; Hung Bui; Emmanuel Tubacher; Greg Solomon; Jung-Eun Park; Izumi Horikawa; Natalay Kouprina; J Carl Barrett; Vladimir Larionov
Journal:  Oncogene       Date:  2002-01-24       Impact factor: 9.867

3.  Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.

Authors:  Tae-Wook Chung; Young-Choon Lee; Jeong-Heon Ko; Cheorl-Ho Kim
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

4.  Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.

Authors:  M Ogami; Y Ikura; S Nishiguchi; T Kuroki; M Ueda; M Sakurai
Journal:  Lab Invest       Date:  1999-01       Impact factor: 5.662

5.  Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.

Authors:  Patrizia Paterlini-Bréchot; Kenichi Saigo; Yoshiki Murakami; Mounia Chami; Devrim Gozuacik; Claude Mugnier; David Lagorce; Christian Bréchot
Journal:  Oncogene       Date:  2003-06-19       Impact factor: 9.867

6.  Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.

Authors:  H Tahara; T Nakanishi; M Kitamoto; R Nakashio; J W Shay; E Tahara; G Kajiyama; T Ide
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

7.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

8.  Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

Authors:  M J Ferber; D P Montoya; C Yu; I Aderca; A McGee; E C Thorland; D M Nagorney; B S Gostout; L J Burgart; L Boix; J Bruix; B J McMahon; T H Cheung; T K H Chung; Y F Wong; D I Smith; L R Roberts
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

  8 in total
  1 in total

1.  Cause-specific telomere factors deregulation in hepatocellular carcinoma.

Authors:  Manale El Idrissi; Valérie Hervieu; Philippe Merle; Franck Mortreux; Eric Wattel
Journal:  J Exp Clin Cancer Res       Date:  2013-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.